BECTON DICKINSON & CO is 19.2x more valuable than LEMAITRE VASCULAR INC by market capitalization ($40.60 B vs $2.11 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LMAT | BDX |
|---|---|---|
| Market cap | $2.11 B | $40.60 B |
| US-listed rank | #2074 | #377 |
| Revenue (latest FY) | $249.60M | $21.84B |
| Net income (latest FY) | $57.70M | $1.68B |
| Net margin | 23.1% | 7.7% |
| P/E (trailing FY) | 36.6 | 24.2 |
| SEC filings | 1,849 | 3,027 |
BECTON DICKINSON & CO is 19.2x more valuable than LEMAITRE VASCULAR INC by market capitalization ($40.60 B vs $2.11 B).
In their latest fiscal years, LEMAITRE VASCULAR INC reported $249.60M in revenue while BECTON DICKINSON & CO reported $21.84B.
Full pages: LEMAITRE VASCULAR INC and BECTON DICKINSON & CO, or browse the full rankings.